Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential pneumococcal vaccination in renal transplant recipients
2007-004590-25Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2009
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of pneumococcal 7-valent conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal disease (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Quantitative serotype-specific IgG antibody response. Started Jan 2009; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2007-004590-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004590-25.